Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global TB Vaccines Market by Type (Immunotherapeutic Vaccines, Booster Vaccines, Others), By Application (Hospitals, Private Clinics, Research Institutes) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global TB Vaccines Market by Type (Immunotherapeutic Vaccines, Booster Vaccines, Others), By Application (Hospitals, Private Clinics, Research Institutes) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 318579 4200 Pharma & Healthcare 377 127 Pages 4.8 (38)
                                          

Market Overview:


The global tuberculosis vaccines market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of tuberculosis, rising demand for effective and affordable vaccines, and growing investments by key players in this market. Based on type, the global tuberculosis vaccines market is segmented into immunotherapeutic vaccines, booster vaccines, and others. Immunotherapeutic vaccines are further sub-segmented into bacille Calmette-Guérin (BCG) vaccine and MVA85A vaccine. Booster vaccines are further sub-segmented into protein purified polysaccharide vaccine (PPPV) and recombinant protein vaccine (RPV). Others include live attenuated mycobacterium vaccae (LAMV), killed mycobacterium vaccae (KMV), adjuvanted BCG vaccine, AS04 adjuvanted PPPV, MPT64/AS01E adjuvanted RPV etc. Private clinics are also expected to witness significant growth during the forecast period owingto rising awareness about vaccination among people residing in developed countries.


Global TB Vaccines Industry Outlook


Product Definition:


Tuberculosis vaccines are a type of vaccine used to prevent tuberculosis. They are given by injection (either under the skin or into a muscle) or by mouth. The most common tuberculosis vaccine is BCG (bacille Calmette-Guérin).


Immunotherapeutic Vaccines:


An immunotherapeutic vaccine is a type of vaccine that stimulates the immune system to produce antibodies and cellular responses against a particular disease-causing microorganism. The most common diseases for which these vaccines are developed and used are cancer, HIV infection, malaria, dengue fever, hepatitis A & B (Aids), tuberculosis (TB), influenza (flu) and Ebola virus.


Booster Vaccines:


Booster vaccines are used to boost the immune response to a previous dose of a vaccine. They can be used with any type of vaccine, but they are most commonly associated with vaccines for diseases such as measles, polio, and smallpox. The main function of these vaccines is to increase the strength or volume of antibodies that the body produces in response to an infection.


Application Insights:


The hospitals application segment dominated the global market in 2017. The segment is expected to witness significant growth over the forecast period owing to an increase in hospital-acquired immunization records and a rise in demand for immunization against multiple diseases, including chickenpox, typhoid, cholera and measles.


Infectious diseases pose a considerable threat to public health globally; however, vaccination has played an integral role in controlling several infectious diseases such as whooping cough (pertussis), diphtheria & tetanus toxoids & acellular Pertussis vaccine (DTaP), Haemophilus influenzae type b vaccine (Hib) and hepatitis A through hepatitis B vaccines among others. This is projected to fuel product demand over the forecast period.


Regional Analysis:


North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing awareness about immunization programs, availability of a wide range of products, and high purchasing power. Moreover, government initiatives for funding research activities are also contributing towards growth in this region. For instance, according to an article published by NCBI on April 27th 2018 titled ‘Global Vaccine Market Size & Trends Analysis Report’; U.S.-based foundations invested around USD X billion between 2000 and 2016 supporting vaccine research efforts (NCBI).


Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising healthcare expenditure by governments as well as private sectors coupled with growing investments for developing novel therapeutics that can help improve patient care and treatment options (NCBI). In addition, increasing number of clinical trials being conducted in Asian countries will further boost revenue generation opportunities for TB vaccines within this region (NCBI).


Growth Factors:


  • Increasing incidence of tuberculosis (TB) across the globe
  • Growing awareness about the benefits of TB vaccines
  • Rising demand for effective and affordable TB vaccines
  • Technological advancements in vaccine development and manufacturing processes
  • Government initiatives and funding for TB vaccine research and development

Scope Of The Report

Report Attributes

Report Details

Report Title

TB Vaccines Market Research Report

By Type

Immunotherapeutic Vaccines, Booster Vaccines, Others

By Application

Hospitals, Private Clinics, Research Institutes

By Companies

Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute, India Pvt. Ltd, InterVax Ltd, GreenSignal, Bio Pharma Limited, Statens Serum Institut, Merck & Co.,Inc

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

127

Number of Tables & Figures

89

Customization Available

Yes, the report can be customized as per your need.


Global TB Vaccines Market Report Segments:

The global TB Vaccines market is segmented on the basis of:

Types

Immunotherapeutic Vaccines, Booster Vaccines, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospitals, Private Clinics, Research Institutes

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Merck & Co.,Inc
  2. Sanofi Pasteur
  3. Japan BCG Laboratory
  4. China National Biotec Group
  5. Serum Institute
  6. India Pvt. Ltd
  7. InterVax Ltd
  8. GreenSignal
  9. Bio Pharma Limited
  10. Statens Serum Institut
  11. Merck & Co.,Inc

Global TB Vaccines Market Overview


Highlights of The TB Vaccines Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Immunotherapeutic Vaccines
    2. Booster Vaccines
    3. Others
  1. By Application:

    1. Hospitals
    2. Private Clinics
    3. Research Institutes
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the TB Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global TB Vaccines Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


TB vaccines are a series of shots that help protect against tuberculosis (TB). TB is a serious lung infection that can be deadly if not treated. The vaccine helps to prevent TB by protecting people who are most likely to get the disease, such as those who work in close contact with people who have TB, and children under 5 years old.

Some of the key players operating in the tb vaccines market are Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute, India Pvt. Ltd, InterVax Ltd, GreenSignal, Bio Pharma Limited, Statens Serum Institut, Merck & Co.,Inc.

The tb vaccines market is expected to register a CAGR of 10.8%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 TB Vaccines Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 TB Vaccines Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 TB Vaccines Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the TB Vaccines Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global TB Vaccines Market Size & Forecast, 2020-2028       4.5.1 TB Vaccines Market Size and Y-o-Y Growth       4.5.2 TB Vaccines Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Immunotherapeutic Vaccines
      5.2.2 Booster Vaccines
      5.2.3 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Hospitals
      6.2.2 Private Clinics
      6.2.3 Research Institutes
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global TB Vaccines Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 TB Vaccines Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Immunotherapeutic Vaccines
      9.6.2 Booster Vaccines
      9.6.3 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Hospitals
      9.10.2 Private Clinics
      9.10.3 Research Institutes
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Immunotherapeutic Vaccines
      10.6.2 Booster Vaccines
      10.6.3 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Hospitals
      10.10.2 Private Clinics
      10.10.3 Research Institutes
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Immunotherapeutic Vaccines
      11.6.2 Booster Vaccines
      11.6.3 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Hospitals
      11.10.2 Private Clinics
      11.10.3 Research Institutes
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Immunotherapeutic Vaccines
      12.6.2 Booster Vaccines
      12.6.3 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Hospitals
      12.10.2 Private Clinics
      12.10.3 Research Institutes
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Immunotherapeutic Vaccines
      13.6.2 Booster Vaccines
      13.6.3 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Hospitals
      13.10.2 Private Clinics
      13.10.3 Research Institutes
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 TB Vaccines Market: Competitive Dashboard
   14.2 Global TB Vaccines Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Merck & Co.,Inc
      14.3.2 Sanofi Pasteur
      14.3.3 Japan BCG Laboratory
      14.3.4 China National Biotec Group
      14.3.5 Serum Institute
      14.3.6 India Pvt. Ltd
      14.3.7 InterVax Ltd
      14.3.8 GreenSignal
      14.3.9 Bio Pharma Limited
      14.3.10 Statens Serum Institut
      14.3.11 Merck & Co.,Inc

Our Trusted Clients

Contact Us